Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors.

Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors.

<h4>Background</h4>Reports on metabolic syndrome in nephroblastoma and neuroblastoma survivors are scarce. Aim was to evaluate the occurrence of and the contribution of treatment regimens to the metabolic syndrome.<h4>Patients and methods</h4>In this prospective study 164 sub...

Full description

Bibliographic Details
Main Authors: Marjolein van Waas, Sebastian J C M M Neggers, Hein Raat, Caroline M van Rij, Rob Pieters, Marry M van den Heuvel-Eibrink
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23251703/pdf/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23251703/pdf/?tool=EBI

Similar Items